Thema
prev ...
Medical Condition: Acute respiratory distress syndrome caused by Covid-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
6
Medical Condition: Acute respiratory distress syndrome due to COVID-19 viral pneumonia;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Acute respiratory distress syndrome in patients with COVID-19 MedDRA version: 21.1Level: PTClassification code 10001052Term: Acute respiratory distress syndromeSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Acute respiratory distress syndrome. Acute respiratory distress syndrome;R06.03
2
Medical Condition: Acute respiratory infection caused by COVID-19. COVID-19, virus not identified;U07.2
2
Medical Condition: Adult hospitalized patients suffering from COVID-19. MedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
4
Medical Condition: Adult patients over 70 years of age diagnosed by COVID-19 with outpatient follow-up MedDRA version: 20.0Level: PTClassification code 10070255Term: Coronavirus test positiveSystem Organ Class: 10022891 - Investigations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Adult patients suffering from mild COVID-19 with cough and at least one other symptoms will be recruited for this study. MedDRA version: 23.0Level: LLTClassification code 10084272Term: SARS-CoV-2 infectionSystem Organ Class: 100000004862 MedDRA version: 20.0Level: PTClassification code 10011224Term: CoughSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Adult patients with COVID-19 and severe hypoxia. MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862 MedDRA version: 21.1Level: PTClassification code 10021143Term: HypoxiaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Adult patients with SARS-CoV-2 infection (COVID19) requiring hospital admission for pneumonia. Who present pcr = 66 mg/L and =150 mg/L at inclusion or Pandemic score [13] on admission > 200 with pcr 9.7-149 mg/L at inclusion. WHO scale level 4 [14], with need for oxygen therapy in NG = 1 lpm to maintain saturation = 94%. ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Adult patients with a diagnosis of COVID-19 requiring hospitalization in a non-ICU and on prior therapy with RAS blockers;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Adult paucisymptomatic COVID-19 patients MedDRA version: 20.0Level: HLGTClassification code 10047438Term: Viral infectious disordersSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]
4
Medical Condition: Adult respiratory distress syndrome (ARDS) secondary to SARS-CoV-2;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: Adults with congenital or acquired B cell/antibody deficiency MedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 100000004865;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Aged patients at risk of COVID-19 infection MedDRA version: 20.0Level: LLTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Airborne transmitted disease;COVID-19; Airborne transmitted disease COVID-19;Infection - Other infectious diseases;Respiratory - Other respiratory disorders / diseases
2
Medical Condition: Airway procedures;Covid-19; Airway procedures Covid-19;Anaesthesiology - Anaesthetics;Respiratory - Other respiratory disorders / diseases;Infection - Other infectious diseases
2
Medical Condition: All patients who have developed and survived ARDS linked to COVID-19 infection, admitted to intensive care units, meeting the study's inclusion criteria may be included in this research.;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: Allogeneic hematopoietic stem cell recipients;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: An observational study in healthy, differently PFAS-exposed subjects to check if PFAS modifies the immunological response to SARS-CoV-2 vaccination. The immunological response is quantified as SARS-CoV-2-specific IgG antibody production and T-cell activity. MedDRA version: 23.0Level: LLTClassification code 10084462Term: SARS-CoV-2 vaccinationSystem Organ Class: 100000004865 MedDRA version: 23.1Level: LLTClassification code 10084465Term: COVID-19 vaccinationSystem Organ Class: 100000004865;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Anosmia. Anosmia;R43.0
4
Medical Condition: Antibody and cellular response 28 days after the first dose of COVID-19 vaccine (Moderna) and then 33 weeks after the second dose and 8-12 weeks after the third dose in clinically stable patients with functional kidney transplantation.;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: Anxiety and quality of life.
2
Medical Condition: Anxiety; Novel Coronavirus Pneumonia (COVID-19)
4
Medical Condition: Anxiety;Depression; Anxiety Depression;Mental Health - Anxiety;Mental Health - Depression
2
Medical Condition: Anxiety;Depression;COVID-19; Anxiety Depression COVID-19;Mental Health - Anxiety;Mental Health - Depression;Infection - Other infectious diseases
2
Medical Condition: Anxiety;Depression;COVID-19; Anxiety Depression COVID-19;Mental Health - Anxiety;Mental Health - Depression;Infection - Other infectious diseases;Respiratory - Other respiratory disorders / diseases
2
Medical Condition: Asthma. Asthma
2
Medical Condition: Atrial fibrillation;Permanent pacemaker;Implantable cardioverter defibrillator; Atrial fibrillation Permanent pacemaker Implantable cardioverter defibrillator;Cardiovascular - Other cardiovascular diseases
2
Medical Condition: Autism Spectrum Disorder
2
Medical Condition: Autism Spectrum Disorder.
2
Medical Condition: Auto Immune Rheumatic Diseases (AIRD) and patients without rheumatic autoimmune diseases (control group). MedDRA version: 20.0Level: PTClassification code 10072736Term: Rheumatic disorderSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disorders;Therapeutic area: Body processes [G] - Immune system processes [G12]
2
Medical Condition: BNT162b2 mRNA Covid-19 vaccine immunogenicity among healtcare workers Not Applicable
2
Medical Condition: Biopsychosocial health; novel coronavirus pneumonia (COVID19)
2
Medical Condition: Breast Cancer. Malignant neoplasm of breast
2
Medical Condition: Breast cancer
2
Medical Condition: Breathing difficulty ;COVID-19;Other respiratory tract infection ; Breathing difficulty COVID-19 Other respiratory tract infection ;Respiratory - Other respiratory disorders / diseases
2
Medical Condition: COIVD-19 patient. covid-19, virus identified;U07.1
2
Medical Condition: COVID - 19. Coronavirus infection, unspecified;B34.2
2
Medical Condition: COVID - 19. Coronavirus infection, unspecified;U07.01
2
Medical Condition: COVID -19 disease.
2
Medical Condition: COVID 19 MedDRA version: 20.0Level: LLTClassification code 10062357Term: SIRSSystem Organ Class: 100000004867;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
4
Medical Condition: COVID 19 MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
2
Medical Condition: COVID 19 PNEUMONIA. This code assigned to a disease diagnosis of COVID-19 confirmed by laboratory testing.;U07.1
2
Medical Condition: COVID 19 infection;Therapeutic area: Diseases [C] - Virus Diseases [C02]
2
Medical Condition: COVID 19 or SARS-CoV-2 Infection; COVID 19 or SARS-CoV-2 Infection;Respiratory - Other respiratory disorders / diseases;Infection - Other infectious diseases
2
Medical Condition: COVID 19.
2
Medical Condition: COVID 19. COVID-19, virus identified;U07.1
2
Medical Condition: COVID 19. Corona virus infection, unspecified;U07.1
8
Medical Condition: COVID 19. U07.1;U07.1
2
mehr ...